National Heart, Lung, and Blood Institute; Amended Notice of Meeting, 31771-31772 [2023-10649]

Download as PDF Federal Register / Vol. 88, No. 96 / Thursday, May 18, 2023 / Notices Dated: May 12, 2023. Tyeshia M. Roberson-Curtis, Program Analyst, Office of Federal Advisory Committee Policy. DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2023–10614 Filed 5–17–23; 8:45 am] Center for Scientific Review; Amended Notice of Meeting BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. lotter on DSK11XQN23PROD with NOTICES1 Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed). Date: June 13, 2023. Time: 12:00 p.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3F52, Rockville, MD 20892 (Virtual Meeting). Contact Person: Lindsey M. Pujanandez, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3F52, Rockville, MD 20852, (240) 627–3206, lindsey.pujanandez@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: May 12, 2023. Tyeshia M. Roberson-Curtis, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2023–10616 Filed 5–17–23; 8:45 am] BILLING CODE 4140–01–P VerDate Sep<11>2014 19:05 May 17, 2023 Jkt 259001 National Institutes of Health Notice is hereby given of a change in the meeting of the Center for Scientific Review Special Emphasis Panel, May 26, 2023, 10:00 a.m. to 2:00 p.m., National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, which was published in the Federal Register on May 3, 2023, FR Doc. No. 2023–09379, 88 FR 27918. This notice is being amended to change the Panel Name of the meeting from Center for Scientific Review Special Emphasis Panel to Center for Scientific Review Special Emphasis Panel PAR–22–233: Time-Sensitive Opportunities for Health Research. The meeting is closed to the public. Dated: May 15, 2023. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2023–10648 Filed 5–17–23; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Human Genome Research Institute; Notice of Closed Meetings Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Human Genome Research Institute Special Emphasis Panel; Genomic Community Resources. Date: June 7, 2023. Time: 1:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Human Genome Research Institute, National Institutes of Health, 6700B Rockledge Drive, Room 3189, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Keith McKenney, Ph.D., Scientific Review Officer, National Human PO 00000 Frm 00103 Fmt 4703 Sfmt 4703 31771 Genome Research Institute, National Institutes of Health, 6700B Rockledge Drive, Suite 3000, Bethesda, MD 20892, (301) 594– 4280, mckenneyk@mail.nih.gov. Name of Committee: National Human Genome Research Institute Special Emphasis Panel; Nucleic Acid Sequencing Technology. Date: June 16, 2023. Time: 1:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Human Genome Research Institute, National Institutes of Health, 6700B Rockledge Drive, Room 3189, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Keith McKenney, Ph.D., Scientific Review Officer, National Human Genome Research Institute, National Institutes of Health, 6700B Rockledge Drive, Suite 3000, Bethesda, MD 20892, (301) 594– 4280, mckenneyk@mail.nih.gov. Name of Committee: National Human Genome Research Institute Special Emphasis Panel; Early Career and Workforce Diversity in Genomics. Date: June 20, 2023. Time: 12:00 p.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Human Genome Research Institute, National Institutes of Health, 6700B Rockledge Drive, Room 3189, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Sarah Jo Wheelan, Ph.D., Scientific Review Officer, Scientific Review Branch, National Institute for Human Genome Research, National Institutes of Health, 6700B Rockledge Drive, Room 3180, Bethesda, MD 20892, (301) 402–8823 wheelansj@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human Genome Research, National Institutes of Health, HHS) Dated: May 15, 2023. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2023–10646 Filed 5–17–23; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the National Heart, Lung, and Blood Advisory Council, June 6, 2023, 9:00 a.m. to June 6, 2023, 5:00 p.m., National Institutes of Health, Rockledge I, 6705 Rockledge Drive, Bethesda, MD 20892 which was published in the Federal Register on May 09, 2023, FR Document No. 2023– 09862, 88 FRN 29914. This notice is being amended to correct the time for the National Heart, Lung, and Blood Advisory Council closed session on June 6, 2023, that was E:\FR\FM\18MYN1.SGM 18MYN1 31772 Federal Register / Vol. 88, No. 96 / Thursday, May 18, 2023 / Notices previously published as 9:00 a.m. to 10:00 p.m. The correct time is from 9:00 a.m. to 10:00 a.m. The meeting is partially closed to the public. Dated: May 15, 2023. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2023–10649 Filed 5–17–23; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Fiscal Year (FY) 2023 Notice of Supplemental Funding Opportunity Substance Abuse and Mental Health Services Administration, Department of Health and Human Services (HHS). ACTION: Notice of intent to award supplemental funding. AGENCY: This notice is to inform the public that the Substance Abuse and Mental Health Services Administration (SAMHSA) is supporting a supplement in scope of the original award for the one grant recipient, the Community Anti-Drug Coalitions of America (CADCA), funded in FY 2019 under the National Anti-Drug Coalitions Training and Workforce Development award, Notice of Funding Opportunity (NOFO) SP–19–002. The recipient may receive up to $175,000 and the project period will be extended by 12 months until November 30, 2024. The supplemental funding to CADCA will be used to continue the Voices of Youth Training Initiative. The Voices of Youth Training Initiative has shown positive results, and the continuation of the program will support finalizing the sustainability and scalability beyond the supplements. The supplement will continue to connect the Future Health Professionals (HOSA) national student organization with CADCA to support youth-led strategic planning for the prevention field and develop leadership skills for the future workforce. This supplement will also allow CADCA to provide HOSA students an opportunity to both learn about and provide valuable input into strategic initiatives for prevention. FOR FURTHER INFORMATION CONTACT: David Wilson, Substance Abuse and Mental Health Services Administration, 5600 Fishers Lane, Rockville, MD 20857, telephone (240) 276–2558; email: david.wilson@samhsa.hhs.gov. SUPPLEMENTARY INFORMATION: lotter on DSK11XQN23PROD with NOTICES1 SUMMARY: VerDate Sep<11>2014 19:05 May 17, 2023 Jkt 259001 Funding Opportunity Title: FY 2019 National Anti-Drug Coalitions Training and Workforce Development Grant SP– 19–002. Assistance Listing Number: 93.243. Authority: Section 516 of the Public Health Services Act, as amended. Justification: The purpose of the National Anti-Drug Coalitions Training and Workforce Development grant program is to provide education, training, and technical assistance for coalition leaders and community teams, with an emphasis on the development of coalitions serving economically disadvantaged areas. The program disseminates evaluation tools, mechanisms, and measures to better assess and document coalition performance measures and outcomes and bridge the gap between research and practice by translating knowledge from research into practical application. Eligibility for this supplemental funding is limited to the FY 2019 National AntiDrug Coalitions Training and Workforce Development recipient, CADCA. CADCA has special expertise providing training and workforce development for thousands of members of community coalitions dedicated to preventing substance use. This organization is uniquely positioned to train youth in community-focused prevention activities being funded through this supplement. This is not a formal request for application. Assistance will only be provided to the National Anti-Drug Coalitions Training and Workforce Development grant recipient funded in FY 2019 under the National Anti-Drug Coalitions Training and Workforce Development Cooperative Agreement SP–19–002 based on the receipt of a satisfactory application and associated budget that is approved by a review group. Dated: May 15, 2023. Ann Ferrero, Public Health Analyst. [FR Doc. 2023–10632 Filed 5–17–23; 8:45 am] BILLING CODE 4162–20–P PO 00000 DEPARTMENT OF HOMELAND SECURITY U.S. Citizenship and Immigration Services [OMB Control Number 1615–0014] Agency Information Collection Activities; Extension, Without Change, of a Currently Approved Collection: Declaration of Financial Support U.S. Citizenship and Immigration Services, Department of Homeland Security. ACTION: 30-Day notice. AGENCY: The Department of Homeland Security (DHS), U.S. Citizenship and Immigration Services (USCIS) will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and clearance in accordance with the Paperwork Reduction Act of 1995. The purpose of this notice is to allow an additional 30 days for public comments. DATES: Comments are encouraged and will be accepted until June 20, 2023. ADDRESSES: Written comments and/or suggestions regarding the item(s) contained in this notice, especially regarding the estimated public burden and associated response time, must be submitted via the Federal eRulemaking Portal website at https:// www.regulations.gov under e-Docket ID number USCIS–2006–0072. All submissions received must include the OMB Control Number 1615–0014 in the body of the letter, the agency name and Docket ID USCIS–2006–0072. FOR FURTHER INFORMATION CONTACT: USCIS, Office of Policy and Strategy, Regulatory Coordination Division, Samantha Deshommes, Chief, telephone number (240) 721–3000 (This is not a toll-free number; comments are not accepted via telephone message.). Please note contact information provided here is solely for questions regarding this notice. It is not for individual case status inquiries. Applicants seeking information about the status of their individual cases can check Case Status Online, available at the USCIS website at https://www.uscis.gov, or call the USCIS Contact Center at 800–375–5283 (TTY 800–767–1833). SUPPLEMENTARY INFORMATION: SUMMARY: Comments The information collection notice was previously published in the Federal Register on March 09, 2023, at 88 FR 14633, allowing for a 60-day public comment period. USCIS did receive one Frm 00104 Fmt 4703 Sfmt 4703 E:\FR\FM\18MYN1.SGM 18MYN1

Agencies

[Federal Register Volume 88, Number 96 (Thursday, May 18, 2023)]
[Notices]
[Pages 31771-31772]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-10649]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Amended Notice of 
Meeting

    Notice is hereby given of a change in the meeting of the National 
Heart, Lung, and Blood Advisory Council, June 6, 2023, 9:00 a.m. to 
June 6, 2023, 5:00 p.m., National Institutes of Health, Rockledge I, 
6705 Rockledge Drive, Bethesda, MD 20892 which was published in the 
Federal Register on May 09, 2023, FR Document No. 2023-09862, 88 FRN 
29914.
    This notice is being amended to correct the time for the National 
Heart, Lung, and Blood Advisory Council closed session on June 6, 2023, 
that was

[[Page 31772]]

previously published as 9:00 a.m. to 10:00 p.m. The correct time is 
from 9:00 a.m. to 10:00 a.m. The meeting is partially closed to the 
public.

    Dated: May 15, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-10649 Filed 5-17-23; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.